Alliance Pharma plc (APH.L)
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics. It provides its products under the Aloclair, Anbesol, Asthon and Parsons, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. Alliance Pharma plc was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom.
Company Info
| ISIN | GB0031030819 |
|---|---|
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
Highlights
| Market Cap | £188.87M |
|---|---|
| EPS | -£0.01 |
| Revenue (TTM) | £170.05M |
| Gross Profit (TTM) | £101.68M |
| EBITDA (TTM) | £31.47M |
| Year Range | £33.70 - £71.45 |
| Target Price | £67.43 |
| Short % | 98.00% |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of £10,000 in Alliance Pharma plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Alliance Pharma plc had a return of -16.05% year-to-date (YTD) and -47.81% in the last 12 months. Over the past 10 years, Alliance Pharma plc had an annualized return of 1.33%, while the S&P 500 had an annualized return of 10.33%, indicating that Alliance Pharma plc did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -16.05% | 5.21% |
| 1 month | -14.36% | -4.30% |
| 6 months | -11.92% | 18.42% |
| 1 year | -47.81% | 21.82% |
| 5 years (annualized) | -14.22% | 11.27% |
| 10 years (annualized) | 1.33% | 10.33% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -7.28% | 10.92% | -4.68% | -14.36% | ||||||||
| 2023 | -15.33% | -3.25% | 4.52% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of APH.L is 7, indicating that it is in the bottom 7% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Alliance Pharma plc(APH.L)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Alliance Pharma plc (APH.L) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Alliance Pharma plc granted a 0.03% dividend yield in the last twelve months. The annual payout for that period amounted to £0.01 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | £0.01 | £0.01 | £0.02 | £0.02 | £0.01 | £0.02 | £0.01 | £0.81 | £1.13 | £1.05 | £0.94 | £0.31 |
Dividend yield | 0.03% | 0.03% | 0.03% | 0.02% | 0.01% | 0.02% | 0.02% | 1.21% | 2.39% | 2.44% | 2.58% | 0.75% |
Monthly Dividends
The table displays the monthly dividend distributions for Alliance Pharma plc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | £0.00 | £0.00 | £0.00 | £0.00 | ||||||||
| 2023 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.01 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
| 2022 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.01 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.01 |
| 2021 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.01 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.01 |
| 2020 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.01 |
| 2019 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.01 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.01 |
| 2018 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.01 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
| 2017 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.81 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
| 2016 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.73 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.40 |
| 2015 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.67 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.38 |
| 2014 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.61 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.33 |
| 2013 | £0.01 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.30 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Alliance Pharma plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Alliance Pharma plc was 95.30%, occurring on Dec 23, 2008. Recovery took 1646 trading sessions.
The current Alliance Pharma plc drawdown is 70.81%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -95.3% | Nov 26, 2001 | 1130 | Dec 23, 2008 | 1646 | Jul 21, 2015 | 2776 |
| -70.81% | Mar 29, 2022 | 524 | Apr 29, 2024 | — | — | — |
| -42.11% | Jun 15, 2018 | 450 | Mar 23, 2020 | 297 | May 27, 2021 | 747 |
| -31.12% | Aug 11, 2015 | 222 | Jun 27, 2016 | 345 | Nov 3, 2017 | 567 |
| -15.59% | Feb 2, 2022 | 24 | Mar 7, 2022 | 14 | Mar 25, 2022 | 38 |
Volatility
Volatility Chart
The current Alliance Pharma plc volatility is 7.02%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |